Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

PHASE4CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Ulcerative Colitis
Interventions
DRUG

oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone

maximal oral 5-ASA+/-topical 5-ASA+IV corticosteroids

DRUG

corticosteroids only

IV corticosteroids only

Trial Locations (10)

52621

Sheba Medical Center, Tel Litwinsky

Unknown

6th affiliated hospital of Sun yat-sen university, Guangzhou

Department of Gastroenterology and Hepatology,The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

Service de Gastrologie-Entérologie-Hépatologie, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Etienne

Department of Gastroenterology Venizeleio General Hospital, Leoforos Knosou, Heraklion

Department of Gastroenterology, University Hospital & Medical School of Ionnina, Ioannina

Gastroenterology department, Soroka medical center, Beersheba

Università di Roma Sapienza, Rome

Zvezdara University Clinical Center, Gastroenterology Department, Belgrade

nstitute of Gastroenterology and Department of Internal Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT01941589 - Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis | Biotech Hunter | Biotech Hunter